Point sur les cancers du poumon en 2010

B. Besse; S. Vignot; J. C. Soria

doi:10.1684/bdc.2010.1026

Point sur les cancers du poumon en 2010

B. Besse, S. Vignot, J. C. Soria

Résultats de recherche: Contribution à un journal › Article › Revue par des pairs

2 Citations (Scopus)

Résumé

The year 2009 has lead to new data clearly impacting therapeutic management strategies in NSCLC. Personalized medicine is becoming a reality for patients with EGFR mutation as well as for the recruitment of patients in certain clinical trials (EML4-ALK translocation, KRAS mutation...). Maintenance trials are based on questionable statistical designs but this approach may have an interest in certain subset of patients. Little improvements are being achieved in SCLC and locally advanced NSCLC.

Titre traduit de la contribution	Lung cancer: An update in 2010
langue originale	Français
Pages (de - à)	161-169
Nombre de pages	9
journal	Bulletin du Cancer
Volume	97
Numéro de publication	1
Les DOIs	https://doi.org/10.1684/bdc.2010.1026
état	Publié - 1 janv. 2010

mots-clés

Chemotherapy
EGFR
Lung cancer
Maintenance
Targeted therapies

Accès au document

10.1684/bdc.2010.1026

Autres fichiers et liens

Lien vers la publication dans Scopus

Contient cette citation

@article{7ebe12de26414c279eccbedbaeca26d5,

title = "Point sur les cancers du poumon en 2010",

abstract = "The year 2009 has lead to new data clearly impacting therapeutic management strategies in NSCLC. Personalized medicine is becoming a reality for patients with EGFR mutation as well as for the recruitment of patients in certain clinical trials (EML4-ALK translocation, KRAS mutation...). Maintenance trials are based on questionable statistical designs but this approach may have an interest in certain subset of patients. Little improvements are being achieved in SCLC and locally advanced NSCLC.",

keywords = "Chemotherapy, EGFR, Lung cancer, Maintenance, Targeted therapies",

author = "B. Besse and S. Vignot and Soria, {J. C.}",

year = "2010",

month = jan,

day = "1",

doi = "10.1684/bdc.2010.1026",

language = "Fran{\c c}ais",

volume = "97",

pages = "161--169",

journal = "Bulletin du Cancer",

issn = "0007-4551",

number = "1",

}

TY - JOUR

T1 - Point sur les cancers du poumon en 2010

AU - Besse, B.

AU - Vignot, S.

AU - Soria, J. C.

PY - 2010/1/1

Y1 - 2010/1/1

N2 - The year 2009 has lead to new data clearly impacting therapeutic management strategies in NSCLC. Personalized medicine is becoming a reality for patients with EGFR mutation as well as for the recruitment of patients in certain clinical trials (EML4-ALK translocation, KRAS mutation...). Maintenance trials are based on questionable statistical designs but this approach may have an interest in certain subset of patients. Little improvements are being achieved in SCLC and locally advanced NSCLC.

AB - The year 2009 has lead to new data clearly impacting therapeutic management strategies in NSCLC. Personalized medicine is becoming a reality for patients with EGFR mutation as well as for the recruitment of patients in certain clinical trials (EML4-ALK translocation, KRAS mutation...). Maintenance trials are based on questionable statistical designs but this approach may have an interest in certain subset of patients. Little improvements are being achieved in SCLC and locally advanced NSCLC.

KW - Chemotherapy

KW - EGFR

KW - Lung cancer

KW - Maintenance

KW - Targeted therapies

UR - http://www.scopus.com/inward/record.url?scp=75749098539&partnerID=8YFLogxK

U2 - 10.1684/bdc.2010.1026

DO - 10.1684/bdc.2010.1026

M3 - Article

C2 - 20028651

AN - SCOPUS:75749098539

SN - 0007-4551

VL - 97

SP - 161

EP - 169

JO - Bulletin du Cancer

JF - Bulletin du Cancer

IS - 1

ER -